Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SE Asia Government Leaders to Discuss Move Towards Self-Sufficiency in Plasma Fractionation

Published: Thursday, August 29, 2013
Last Updated: Thursday, August 29, 2013
Bookmark and Share
Self-sufficiency is important to reduce costs, prevent blood shortages and meet the transfusion requirements of patients.

At the 63rd World Health Assembly, WHO member nations were encouraged "to take all the necessary steps to establish, implement and support nationally-coordinated, efficiently managed and sustainable blood and plasma programmes according to availability of resources, with the aim of achieving self-sufficiency".

Currently, excluding China, plasma fractionation plants are only available in the US, Europe, Japan, South Korea and Australia. Most of these fractionators are focused on the European and US markets and only supply Asia with excess product. Although a few high development index (HDI) countries in the Asia Pacific region have sufficient access to a broad portfolio of plasma products through domestic or contract plasma fractionation programmes, the volume of plasma fractionated in the region is too low to meet the needs, resulting in high prices.

Recognizing the importance of self-sufficiency to reduce costs, prevent blood shortages and meet the transfusion requirements of patients, a number of South-East Asian countries are moving towards setting up domestic fractionation plants.

Earlier this month, Malaysia’s Strovi Tel Sdn Bhd announced the construction of the country’s first fractionation plant through a partnership with LFB - Laboratoire francais du Fractonnement of des Biotechnologies – also stating its plans to further expand its business eventually into the South-East Asian and Middle East markets. Thailand’s Thai Red Cross Society (TRCS) also announced a partnership with Korea’s Green Cross, in January 2013, to design and construct a blood plasma separating facility in the Chon Buri province. While Malaysia and Thailand make headway, countries like Indonesia, Phillippines and Singapore are not far behind from self-sustenance.

At the upcoming Bioplasma World Asia 2013 gathering (co-located with Asia’s most prominent bloodborne Pathogen workshop) taking place on 3-5 September 2013 in Bali, health representatives from these and many other Asian more countries, will get together with international plasma fractionators, blood establishments, and technology providers  to explore opportunities and viable partnerships to meet the persistently rising demand of the Asian blood and bioplasma products market.

Some of the confirmed fractionators and government bodies attending this event include Central Blood Collection, Egypt, Indonesian Red Cross, Indonesia, Ministry Of Health, Kuwait, Ministry Of Health, Phillippines, National Institute of Hematology and Blood Transfusion, Vietnam, National Institute of Biologicals, India, Baxter Healthcare, Austria, Greencross, Korea, Blood Product Research Organization, Japan, CSL Behring, Australia, Cordlife Blood Center, Singapore, Red Crescent Society, Brunei, Red Crescent Society, Malaysia, LFB,  France, and Prime Biologics, Singapore.

Technology providers like Sartorius Stedim Biotech, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd, Merck Millipore, Novartis, Nigale, GFE Blut, Dometic, ProMetic, Fresenius Kabi, Neste Jacobs, Boccard, Roche, Abbott, Cerus, will also be present.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Improving Regenerative Medicine
Lab-created stem cells may lack key characteristics, UCLA research finds.
Muscles on-a-Chip
This study may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Bile Acid Supports Production of Blood Stem Cells
A research group at Lund University has been able to show that bile acid is transferred from the mother to the foetus via the placenta to enable the foetus to produce blood stem cells.
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Edited Stem Cells Offer Hope of Precision Therapy for Blindness
Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue.
Hacking the Programs of Cancer Stem Cells
All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!